Armistice Capital, LLC Reports New 7.11% Stake in Nuwellis, Inc. (NUWE)

On May 15, 2026, Armistice Capital, LLC and its managing member, Steven Boyd, filed a Schedule 13G disclosing a new 7.11% ownership stake in Nuwellis, Inc. (NUWE). The reporting persons reported beneficial ownership of 1,055,496 shares of common stock as of the event date on March 31, 2026. Armistice Capital serves as the investment manager to the Armistice Capital Master Fund Ltd., which is the direct holder of the shares. Under the terms of their Investment Management Agreement, Armistice Capital exercises shared voting and dispositive power over these securities. The filing indicates that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. This position represents a significant increase from a previous 0% holding, establishing Armistice Capital as a substantial institutional shareholder in the Minnesota-based medical device company.